Navigation Links
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2009 Financial Results Conference Call
Date:7/23/2009

CARLSBAD, Calif., July 23 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast:

    What:       Isis Pharmaceuticals' Second Quarter 2009 Financial Results

    When:       Thursday, August 6, 2009 at 8:30 a.m. ET / 5:30 a.m. PT

    Where:      www.isispharm.com

    How:        Live on the Internet.  Simply log onto our Web site listed above.

    Contacts:   Kristina Lemonidis
                Director, Investor Relations
                (760) 603-2490

                Amy Blackley, Ph.D.
                Assistant Director, Corporate Communications
                (760) 603-2772

If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NHP Announces Second Quarter Earnings Release Date and Webcast/Conference Call
2. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results
3. CorVel Announces Earnings Release Webcast
4. Kendle Announces Details Regarding Second Quarter 2009 Earnings Conference Call and Webcast
5. Smart Balance to Host Webcast/Conference Call on 2009 Second-Quarter Results
6. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
7. NBTY to Webcast Presentation at Oppenheimer 9th Annual Consumer, Gaming, Lodging & Leisure Conference; Announces Fiscal Third Quarter Preliminary Unaudited Net Sales Results
8. Boston Scientific to Webcast Conference Call Discussing Second Quarter Financial Results
9. Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call
10. Mylan Schedules Second Quarter 2009 Financial Results Conference Call and Live Webcast
11. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. Announces Second Quarter 2009 Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & Associates’ ... years of experience in leading technology and human resources operations for health care, ... Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , Innovative Leaders ...
(Date:5/26/2016)... Farmington, CT; Scottsdale, AZ (PRWEB) , ... ... ... Leading insights consultancy, Actûrus , is happy to announce the launch ... linear thinking of the funnel model to reflect the dynamic landscape of ...
(Date:5/26/2016)... Madeira Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... island connected to the mainland by a single drawbridge, citizens formed an organization, Madeira ... increase already congested traffic and change the small town center to a high rise ...
(Date:5/26/2016)... ... May 26, 2016 , ... Women’s athletic ... host their second pop-up shop for three consecutive weekends. The pop-up shop is ... Santa Barbara community, a community full of women who appreciate the most premium ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food ... androgenetic alopecia in both men and women. To date, the company is the first ... clearance for any adult who suffers with androgenetic alopecia. , “This new level ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice ... officer, today. In his new role, Marziani will lead the company,s business development and ... to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
Breaking Medicine Technology: